{"protocolSection": {"identificationModule": {"nctId": "NCT01932294", "orgStudyIdInfo": {"id": "Medamacs"}, "organization": {"fullName": "National Heart, Lung, and Blood Institute (NHLBI)", "class": "NIH"}, "briefTitle": "Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support", "officialTitle": "Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support", "acronym": "Medamacs"}, "statusModule": {"statusVerifiedDate": "2017-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2013-04", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2017-01-20", "type": "ACTUAL"}, "completionDateStruct": {"date": "2017-01-20", "type": "ACTUAL"}, "studyFirstSubmitDate": "2013-04-12", "studyFirstSubmitQcDate": "2013-08-27", "studyFirstPostDateStruct": {"date": "2013-08-30", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2018-09-20", "resultsFirstSubmitQcDate": "2018-11-08", "resultsFirstPostDateStruct": {"date": "2018-12-06", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-11-08", "lastUpdatePostDateStruct": {"date": "2018-12-06", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "National Heart, Lung, and Blood Institute (NHLBI)", "class": "NIH"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "Medamacs is a prospective, observational study of ambulatory patients with advanced heart failure. The study enrolls patients who have not yet received a Left Ventricular Assist Device (LVAD) but who receive their care at a hospital with a Joint Commission certified mechanical circulatory support program.\n\nMedamacs is funded through the Interagency for Mechanically Assisted Circulatory Support (INTERMACS) NHLBI Contract.", "detailedDescription": "Participants between 18 and 80 years old with low ejection fraction history and hospitalization for heart failure within the past year will be screened for the study. All subjects who have been admitted to the heart failure service will be screened and recruited, either as an inpatient or during their first outpatient follow-up appointment by the investigator and research staff caring for patients in the advanced heart failure program.\n\nEligibility for enrollment will be based only upon information that is clinically available at the time of screening. The history of prior hospitalizations will be available from clinical records.\n\nRoutine evaluation and triage of ambulatory patients with advanced heart disease includes echocardiography and functional assessment with peak oxygen consumption and frequently 6 minute walk distance. The elements of information required for estimation of the Seattle Heart Failure Risk score will be gleaned from laboratory data, or imputed as described in the Seattle score literature. The research coordinator will enter this data onto a currently available website for calculation of the Seattle score.\n\nEligibility will be determined by the inclusion and exclusion criteria and the study research team will approach individual subjects who are potential candidates for participation once the subject's primary physician has given permission to approach. Only persons with a scientific or ethical reason will be excluded. Incarcerated prisoners have been excluded by this protocol.\n\nParticipants will be followed every 6 months for 24 months after two baseline visits. The 6 month and 18 month follow ups consist of telephone interviews. Follow ups at 12 months and 24 months consists of routine clinical visits.\n\nApproximately 350 patients from 12 centers in the United States will be enrolled over a 12 month period."}, "conditionsModule": {"conditions": ["Heart Failure", "Systolic Heart Failure"], "keywords": ["Advanced Heart Failure", "Refractory Heart Failure", "Mechanical Circulatory Support Device", "Ventricular Assist Device", "Medamacs"]}, "designModule": {"studyType": "OBSERVATIONAL", "patientRegistry": true, "targetDuration": "2 Years", "designInfo": {"observationalModel": "COHORT", "timePerspective": "PROSPECTIVE"}, "enrollmentInfo": {"count": 171, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "MedaMACS participants", "description": "All participants who have met the inclusion criteria."}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Heart Failure Participants Deceased at 24 Months", "description": "Death after the baseline visit up to 24 months", "timeFrame": "6 month intervals after the baseline visit up to 24 months"}], "secondaryOutcomes": [{"measure": "Number of Participants With Known Ventricular Assist Device (VAD) Implantation", "description": "Known VAD implantation after the baseline visit up to 24 months", "timeFrame": "6 month intervals after the baseline visit up to 24 months"}, {"measure": "Number of Participants With Known Heart Transplantation", "description": "Heart transplantation after the baseline visit up to 24 months", "timeFrame": "6 month intervals after the baseline visit up to 24 months"}]}, "eligibilityModule": {"eligibilityCriteria": "INCLUSION CRITERIA:\n\nPatients with Advanced Heart Failure\n\n1. Age 18-80 years\n2. New York Heart Association class III-IV heart failure for 45 of the last 60 days\n3. Left ventricular ejection fraction \u2264 35%\n4. Heart failure diagnosis or typical symptoms for 12 months\n5. Use of evidence based oral medications (beta-blockers, ACE-inhibitors/ARBs, aldosterone antagonist) for at least 3 months prior to enrollment or documented medication contraindication or intolerance.\n6. Hospitalization for heart failure within the previous 12 months (other than for elective procedure)\n7. Informed consent given\n\nIn Addition, they must have at least one of the following:\n\nAn additional unplanned hospitalization during the previous 12 months for a total of at least 2 inpatient hospitalizations lasting \\>24 hours with heart failure as the primary or secondary diagnosis within the previous 12 months\n\nOR\n\n1. Peak oxygen uptake (VO2) \\<55% of age- and sex-predicted (using Wasserman equation) OR a peak VO2 \u226416 ml/kg/min for men and \u226414 ml/kg/min for women in a test with an RER \\>1.08 on cardiopulmonary exercise testing.\n2. 6-minute walk distance \\<300 meters without non-cardiac limitation.\n3. Serum BNP \\> 1000 (NT-proBNP \\> 4000 pg/ml) as outpatient or at hospital discharge.\n\nOR\n\nSeattle Heart Failure Model Score \\> 1.5.\n\nEXCLUSION CRITERIA:\n\n1. Age \\>80 years or \\<18 years\n2. Non-cardiac diagnosis anticipated to limit 2-year survival (\u226530-50% mortality within 2 years from non-cardiac diagnosis)\n3. Primary functional limitation from non-cardiac diagnosis even if not likely to limit survival\n4. QRS \\> 120msec and planned biventricular pacemaker implant or biventricular pacemaker implantation within past 90 days\n5. Current home intravenous inotrope therapy\n6. Chronic hemodialysis or peritoneal dialysis\n7. Scheduled for non-ventricular assist device cardiac surgery on current hospital admission\n8. Obvious anatomical or other major contra-indication to any cardiac surgery in the future (e.g. previous pneumonectomy, advanced connective tissue disease)\n9. Actively listed for heart transplant as UNOS Status 1 or 2\n10. History of cardiac amyloidosis\n11. Dominant lesion of at least moderate aortic or mitral stenosis or congenital structural heart defect.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "80 Years", "stdAges": ["ADULT", "OLDER_ADULT"], "studyPopulation": "Participants will be screened for this study if they are between 18 and 80 years old with low ejection fraction history and hospitalization for heart failure within the past year. All subjects who have been admitted to the heart failure service will be screened and recruited for study participation, either as an inpatient or during their first outpatient follow-up appointment by the investigator and research staff caring for patients in the advanced heart failure program of the enrolling center.", "samplingMethod": "NON_PROBABILITY_SAMPLE"}, "contactsLocationsModule": {"overallOfficials": [{"name": "James K Kirklin, MD", "affiliation": "INTERMACS Principal Investigator", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "University of Alabama at Birmingham", "city": "Birmingham", "state": "Alabama", "zip": "35294", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "Cedars Sinai Medical Center", "city": "Beverly Hills", "state": "California", "zip": "90211", "country": "United States", "geoPoint": {"lat": 34.07362, "lon": -118.40036}}, {"facility": "University of Colorado", "city": "Aurora", "state": "Colorado", "zip": "80045", "country": "United States", "geoPoint": {"lat": 39.72943, "lon": -104.83192}}, {"facility": "University of Iowa Hospitals and Clinics", "city": "Iowa City", "state": "Iowa", "zip": "52242", "country": "United States", "geoPoint": {"lat": 41.66113, "lon": -91.53017}}, {"facility": "Brigham and Women's Hospital", "city": "Boston", "state": "Massachusetts", "zip": "02115", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"facility": "University of Michigan", "city": "Ann Arbor", "state": "Michigan", "zip": "48109", "country": "United States", "geoPoint": {"lat": 42.27756, "lon": -83.74088}}, {"facility": "Duke University", "city": "Durham", "state": "North Carolina", "zip": "27710", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}, {"facility": "Cleveland Clinic Foundation", "city": "Cleveland", "state": "Ohio", "zip": "44195", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "University of Pennsylvania", "city": "Philadelphia", "state": "Pennsylvania", "zip": "19104", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"facility": "University of Pittsburgh", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15213", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "Southwestern Medical Center", "city": "Dallas", "state": "Texas", "zip": "75390", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}]}, "referencesModule": {"references": [{"pmid": "23352390", "type": "BACKGROUND", "citation": "Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Baldwin JT, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013 Feb;32(2):141-56. doi: 10.1016/j.healun.2012.12.004. Erratum In: J Heart Lung Transplant. 2015 Oct;34(10):1356. Timothy Baldwin, J [corrected to Baldwin, J T]."}], "seeAlsoLinks": [{"label": "Click here for more information about this study: MedaMACS", "url": "http://www.intermacs.org"}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "Individual participant data (IPD) is not available. De-identified datasets may be available upon approval."}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "MedaMACS Participants", "description": "All participants who have met the inclusion criteria."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "171"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "72"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "99"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "43"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "8"}]}, {"type": "VAD Implantation", "reasons": [{"groupId": "FG000", "numSubjects": "20"}]}, {"type": "Heart Transplantation", "reasons": [{"groupId": "FG000", "numSubjects": "16"}]}, {"type": "Transferred to other hospitals", "reasons": [{"groupId": "FG000", "numSubjects": "12"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "MedaMACS Participants", "description": "All participants who have met the inclusion criteria."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "171"}]}], "measures": [{"title": "Age, Categorical", "populationDescription": "1 participant missed this variable", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "170"}]}], "categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "53"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "117"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "171"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "59.03", "spread": "10.95"}]}]}]}, {"title": "Sex: Female, Male", "populationDescription": "One participant missing a value for the variable", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "170"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "57"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "113"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "171"}]}], "categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "10"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "160"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "1"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "171"}]}], "categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "47"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "119"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "5"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "171"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "171"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Heart Failure Participants Deceased at 24 Months", "description": "Death after the baseline visit up to 24 months", "populationDescription": "By the end of the follow-up, 43 patients had deceased.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 month intervals after the baseline visit up to 24 months", "groups": [{"id": "OG000", "title": "MedaMACS Participants", "description": "All participants who have met the inclusion criteria. By the end of the follow-up, 43 out of 171 patients died."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "171"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "43"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Known Ventricular Assist Device (VAD) Implantation", "description": "Known VAD implantation after the baseline visit up to 24 months", "populationDescription": "Patients with known endpoints.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 month intervals after the baseline visit up to 24 months", "groups": [{"id": "OG000", "title": "MedaMACS Participants", "description": "All participants who have met the inclusion criteria."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "171"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "20"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants With Known Heart Transplantation", "description": "Heart transplantation after the baseline visit up to 24 months", "populationDescription": "Patients with known endpoints.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "6 month intervals after the baseline visit up to 24 months", "groups": [{"id": "OG000", "title": "MedaMACS Participants", "description": "All participants who have met the inclusion criteria."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "171"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "16"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "After the baseline visit and up to 24 months", "eventGroups": [{"id": "EG000", "title": "MedaMACS Participants", "description": "All participants who have met the inclusion criteria.", "deathsNumAffected": 43, "deathsNumAtRisk": 171, "seriousNumAffected": 93, "seriousNumAtRisk": 171, "otherNumAffected": 12, "otherNumAtRisk": 171}], "seriousEvents": [{"term": "Rehospitalization", "organSystem": "Investigations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "All-cause Rehospitalizations", "stats": [{"groupId": "EG000", "numEvents": 273, "numAffected": 93, "numAtRisk": 171}]}, {"term": "IV Inotropes Dependent at 6 months", "organSystem": "Cardiac disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 12, "numAtRisk": 171}]}], "otherEvents": [{"term": "All-location Infection", "organSystem": "Infections and infestations", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "All-location Infection", "stats": [{"groupId": "EG000", "numEvents": 19, "numAffected": 12, "numAtRisk": 171}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "RongBing Xie", "organization": "University of Alabama at Birmingham", "email": "rongbingxie@uabmc.edu", "phone": "205-975-3624"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2012-11-16", "uploadDate": "2018-11-08T10:05", "filename": "Prot_SAP_000.pdf", "size": 1476458}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000054143", "term": "Heart Failure, Systolic"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M27579", "name": "Heart Failure, Systolic", "asFound": "Systolic Heart Failure", "relevance": "HIGH"}, {"id": "M27583", "name": "Systolic Murmurs", "relevance": "LOW"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}}, "hasResults": true}